Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Karovic
Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies
Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies
Cancer
Cancer Research
Oncology
Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination With Bevacizumab in Patients With Advanced Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
52: Early Standardized Treatment of Critical Blood Pressure (crBP) Elevations Is Associated With a Reduction in Eclampsia
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
A First-In-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients With Advanced Solid Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Which Measurement of Blood Pressure Is More Associated With Albuminuria in Patients With Type 2 Diabetes: Central Blood Pressure or Peripheral Blood Pressure?
Journal of Clinical Hypertension
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Driving Pressure Is Not Associated With Mortality in Mechanically Ventilated Patients Without ARDS
Critical Care
Critical Care
Intensive Care Medicine
Why Driving Pressure Is Not Associated With the Mortality in Non-Ards Patients?
Critical Care
Critical Care
Intensive Care Medicine
Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Clinical Cancer Research
Cancer Research
Oncology
